Flow-Controlled Versus Volume-Controlled Ventilation During Suspension Laryngoscopy
Comparison of Flow-Controlled Ventilation and Volume-Controlled Ventilation on Respiratory Mechanics During Suspension Laryngoscopy: A Prospective Observational Study
1 other identifier
observational
71
1 country
1
Brief Summary
Suspension laryngoscopy presents significant challenges for airway management due to the need to maintain adequate ventilation while providing optimal surgical exposure. Flow-controlled ventilation (FCV) is a novel ventilation mode that delivers constant inspiratory and expiratory flow using a narrow-lumen, cuffed endotracheal tube, potentially improving ventilation efficiency in shared-airway surgeries. This prospective observational study aims to compare flow-controlled ventilation and conventional volume-controlled ventilation in patients undergoing elective suspension laryngoscopy. Respiratory mechanics, hemodynamic parameters, perioperative pulmonary function, and procedure-related complications will be evaluated to assess the feasibility and clinical performance of FCV in this surgical setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2024
CompletedFirst Submitted
Initial submission to the registry
February 3, 2026
CompletedFirst Posted
Study publicly available on registry
June 10, 2026
CompletedJune 10, 2026
June 1, 2026
2 months
February 3, 2026
June 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peak airway pressure
Intraoperative peak airway pressure (cmH2O) measured at predefined time intervals during suspension laryngoscopy.
During surgery with 10 minute intervals
Secondary Outcomes (5)
Respiratory system compliance
Intraoperative period during suspension laryngoscopy with 10 minute intervals.
End tidal carbondioxide
Intraoperative period during suspension laryngoscopy with 10 minute intervals
Peripheral oxygen saturation
Intraoperative period during suspension laryngoscopy with 10 minute intervals.
Forced expiratory volume in one second
30 minutes before surgery and 12 hours after surgery
Forced vital capacity
30 minutes before surgery and 12 hours after surgery
Study Arms (2)
Flow-Controlled Ventilation Group
Patients undergoing elective suspension laryngoscopy who were ventilated using flow-controlled ventilation based on the attending anesthesiologist's clinical preference.
Volume-Controlled Ventilation Group
Patients undergoing elective suspension laryngoscopy who were ventilated using conventional volume-controlled ventilation based on the attending anesthesiologist's clinical preference.
Eligibility Criteria
Adult patients aged 18 to 65 years scheduled for elective suspension laryngoscopy under general anesthesia were included. Eligible participants had an American Society of Anesthesiologists (ASA) physical status of I-III and a body mass index between 18 and 40 kg/m². All participants provided written informed consent prior to participation.
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status I-III
- Scheduled for elective suspension laryngoscopy under general anesthesia
- Body mass index between 18 and 40 kg/m²
- Provision of written informed consent
You may not qualify if:
- Inability to cooperate with pulmonary function testing
- Intraoperative hemodynamic instability or oxygen desaturation (SpO₂ \<92%)
- Requirement for tracheostomy during the procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Training and Research Hospital
Ankara, Ankara, 06530, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Salih Birkan ARI, M.D.
Ankara Trainig and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D. Principal investigator
Study Record Dates
First Submitted
February 3, 2026
First Posted
June 10, 2026
Study Start
December 20, 2023
Primary Completion
February 19, 2024
Study Completion
February 19, 2024
Last Updated
June 10, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data, as the study is an academic, single-center observational study and only aggregate data will be reported.